Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The Gym Group saw 8% revenue growth in 2025, boosted by demand from weight-loss drug users, and plans 75 new gyms.

flag The Gym Group reports strong financial growth in 2025, with 8% revenue rise to £244.9 million and membership up 4% to 923,000, driven by increased demand from users of weight-loss drugs like Mounjaro and Wegovy. flag CEO Will Orr cites these medications as a "tailwind," boosting gym visits as people seek to maintain muscle and sustain results. flag The company plans to open 75 new gyms over the next three years—25 more than before—and launched a £10 million share buyback. flag Analysts view the performance positively, citing growth momentum and strong Gen Z engagement. flag Full-year results are due March 11.

9 Articles